Abstract
Aquagenic (palmoplantar) keratoderma is an uncommon hereditary or sporadic condition, whose pathogenesis is largely uncovered, but characterized by a peculiar transitory palmar and more rarely plantar skin wrinkling after brief water exposure. Association with cystic fibrosis is frequent and related to mutations on the same cystic fibrosis transmembrane conductance regulator gene, usually the ΔF508 mutation, either homozygous or heterozygous. However, aquagenic keratoderma is frequently idiopathic or secondary to other internal organ dysfunctions, as well as drug-induced. Diagnosis is mainly clinical and easily confirmed with an immersion test, if one is aware of this entity. Histopathology is rarely performed, but highly informative of the transient alterations of the stratum corneum and eccrine glands. Sporadic form may resolve spontaneously after a few years or have periods of remission during the life course. For very disturbing conditions, topical aluminum hydroxide and botulinum toxin injections are the most used treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Orphanet version 5.41.0 - Last updated: 2020-11-28. www.orpha.net
English JC, McCollough ML. Transient reactive papulotranslucent acrokeratoderma. J Am Acad Dermatol. 1996;34:686–7.
Onwukwe MF, Mihm MC Jr, Toda K. Hereditary papulotranslucent acrokeratoderma. A new variant of familial punctate keratoderma? Arch Dermatol. 1973;108:108–10.
MacCormack MA, Wiss K, Malhotra R. Aquagenic syringeal acrokeratoderma: report of two teenage cases. J Am Acad Dermatol. 2001;45:124–6.
Yan AC, Sumaira ZA, Alms WJ, et al. Aquagenic palmoplantar keratoderma. J Am Acad Dermatol. 2001;44:696–9.
Itin PH, Lautenschlager S. Aquagenic syringeal acrokeratoderma (transient reactive papulotranslucent acrokeratoderma). Dermatology. 2002;204:8–11.
Belloch I, Vergara G, Albares MP, et al. Aquagenic keratoderma. J Eur Acad Dermatol Venereol. 2003;17:306–7.
Schmults C, Sidhu G, Urbanek W. Aquagenic syringeal acrokeratoderma. Dermatol Online J. 2003;9:27.
Davis LS, Woody CM. Idiopathic aquagenic wrinkling of the palms. Pediatr Dermatol. 2004;21:180.
Yalcin B, Artuz F, Toy GG, et al. Acquired aquagenic papulotranslucent acrokeratoderma. J Eur Acad Dermatol Venereol. 2005;19:638–59.
Saray Y, Seçkin D. Familial aquagenic acrokeratoderma: case reports and review of the literature. Int J Dermatol. 2005;44:906–9.
Xia Y, Gunning ST, Schulz-Butulis BA. Aquagenic syringeal acrokeratoderma. Cutis. 2006;78:304.
Rongioletti F, Tomasini C, Crovato F, Marchesi L. Aquagenic (pseudo) keratoderma: a clinical series with new pathological insights. Br J Dermatol. 2012;167:575–82.
Nazik H, Nazik S, Çoban FG, Demir B. Sporadic and familial cases of aquagenic keratoderma. J Dermatol Case Rep. 2016;10:10–3.
Montoya C, Arias LM, Salazar M, Restrepo R. Water-induced dermatosis: Aquagenic keratoderma. A case report. Biomedica. 2019;39:247–51.
Coelho-Macias V, Fernandes S, Lamarão P, et al. Aquagenic keratoderma associated with a mutation of the cystic fibrosis gene. Rev Port Pneumol. 2013;19:125–8.
Elliott RB. Letter: skin wrinkling in cystic fibrosis. Lancet. 1974;2(7872):108.
Lowes MA, Khaira GS, Holt D. Transient reactive papulotranslucent acrokeratoderma associated with cystic fibrosis. Australas J Dermatol. 2000;41:172–4.
Gild R, Clay CD. Aquagenic wrinkling of the palms in a cystic fibrosis carrier. Australas J Dermatol. 2008;49:19–20.
Misery L, Garçon N, Roguedas AM. Aquagenic palmoplantar keratoderma and cystic fibrosis. Ann Dermatol Venereol. 2009;136:491–2.
Berk DR, Ciliberto HM, Sweet SC, et al. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype–phenotype correlations. Arch Dermatol. 2009;145:1296–9.
Tolland JP, Boyle J, Hall V, et al. Aquagenic wrinkling of the palms in an adult cystic fibrosis population. Dermatology. 2010;221:326–30.
Garçon-Michel N, Roguedas-Contios AM, Rault G, et al. Frequency of aquagenic palmoplantar keratoderma in cystic fibrosis: a new sign of cystic fibrosis? Br J Dermatol. 2010;163:162–6.
Stewart LC, Doe SJ, Bourke SJ, Leech S. Aquagenic palmar wrinkling as a presenting feature of cystic fibrosis gene dysfunction. Clin Exp Dermatol. 2009;34:e647–9.
Weil B, Chaillou E, Troussier F, et al. Aquagenic palmoplantar keratoderma in children with cystic fibrosis. Arch Pediatr. 2013;20:1306–9.
Raynal C, Girodon E, Audrezet MP, et al. CFTR gene variants: a predisposition factor to aquagenic palmoplantar keratoderma. Br J Dermatol. 2019;181:1097–9.
Nadal M, Laudier B, Malinge MC, et al. Aquagenic palmar keratoderma in a patient heterozygous for the mutation c.3197G>C in the CFTR gene. Ann Dermatol Venereol. 2015;142:201–5.
Katz KA, Yan AC, Turner ML. Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the delta F508 CFTR mutation. Arch Dermatol. 2005;141:621–4.
Thomas JM, Durack A, Sterling A, et al. Aquagenic wrinkling of the palms: a diagnostic clue to cystic fibrosis carrier status and non-classic disease. Lancet. 2017;389(10071):846.
Chinazzo C, De Alessandri A, Menoni S, et al. Aquagenic wrinkling of the palms and cystic fibrosis: an Italian study with controls and genotype-phenotype correlations. Dermatology. 2014;228:60–5.
Lim KS, Ng SK. Aquagenic wrinkling of the palms in a boy with a congenital cardiac anomaly. J Eur Acad Dermatol Venereol. 2007;21:985–6.
Gild R, Clay CD, Morey S. Aquagenic wrinkling of the palms in cystic fibrosis and the cystic fibrosis carrier state: a case–control study. Br J Dermatol. 2010;163:1082–4.
Schmutz JL, Barbaud A, Trechot P. Rofecoxib-induced aquagenic edema with puckering of the palms of the hands: the first case. Ann Dermatol Venereol. 2003;130:813.
Vildósola S, Ugalde A. Celecoxib-induced aquagenic keratoderma. Actas Dermosifiliogr. 2005;96:537–9.
Carder KR, Weston WL. Rofecoxib-induced instant aquagenic wrinkling of the palms. Pediatr Dermatol. 2002;19:353–5.
Khuu PT, Duncan KO, Kwan A, et al. Unilateral aquagenic wrinkling of the palms associated with aspirin intake. Arch Dermatol. 2006;142:1661–2.
Ludgate MW, Patel D, Lamb S. Tobramycin-induced aquagenic wrinkling of the palms in a patient with cystic fibrosis. Clin Exp Dermatol. 2009;34:e75–7.
Emiroglu N, Cengiz FP, Su O, Onsun N. Gabapentin-induced aquagenic wrinkling of the palms. Dermatol Online J. 2017;23:13030/qt64k739q5.
Aktaş H. A new trigger for aquagenic wrinkling: isotretinoin. Indian Dermatol Online J. 2019;10:593–4.
Luo DQ. Aquagenic acrokeratoderma: a case with family history and unusual involvements of the palms and soles, and the dorsum of fingers and toes. J Dermatol. 2011;38:612–5.
Houle MC, Al Dhaybi R, Benohanian A. Unilateral aquagenic keratoderma treated with botulinum toxin A. J Dermatol Case Rep. 2010;4:1–5.
Angra D, Angra K, Rodney IJ. Aquagenic palmoplantar keratoderma with dorsal hand involvement in an adolescent female. JAAD Case Rep. 2016;2:239–40.
Pardo J, Sánchez-Motilla JM, Latasa JM. Queratodermia acuagénica de características atípicas [Atypical aquagenic keratoderma]. Actas Dermosifiliogr. 2005;96:540–2.
Dixit N, Sardana K, Tandon S, Singh Y. Atypical aquagenic keratoderma treated with oxybutynin chloride. An Bras Dermatol. 2018;93:308–9.
Flann S, Pembroke A. A localized form of aquagenic syringeal acrokeratoderma. Clin Exp Dermatol. 2010;35:e147–8.
Baldwin BT, Prakash A, Fenske NA, Messina JL. Aquagenic syringeal acrokeratoderma: report of a case with histologic findings. J Am Acad Dermatol. 2006;54:899–902.
Bardazzi F, Savoia F, Dika E, et al. Acquired aquagenic keratoderma. Pediatr Dermatol. 2007;24:197–8.
Hannah-Shmouni F, MacNeil L, Lara-Corrales I, et al. Whole-exome sequencing identifies a homozygous pathogenic variant in TAT in a girl with palmoplantar keratoderma. Mol Genet Metab Rep. 2019;21:100534.
Sezer E, Erkek E, Duman D, et al. Dermatoscopy as an adjunctive diagnostic tool in aquagenic syringeal acrokeratoderma. Dermatology. 2012;225:97–9.
Ghosh SK, Agarwal M, Ghosh S, Dey AK. Aquagenic palmar wrinkling in two Indian patients with special reference to its dermoscopic pattern. Dermatol Online J. 2015;21:1303.
Cabrol C, Bienvenu T, Ruaud L, Girodon E, Noacco G, Delobeau M, Fanian F, Richaud-Thiriez B, Van Maldergem L, Aubin F. Aquagenic palmoplantar keratoderma as a CFTR-related disorder. Acta Derm Venereol. 2016;96:848–9.
Martín Carmona J, Gómez Moyano E, Gómez Huelgas R, Martínez PL. Aquagenic keratoderma and cystic fibrosis screening. Med Clin (Barc). 2020;S0025-7753(20):30509–1.
Butler EG, Derienzo DP, Harford R. Painful plaque on a young man. Eccrine angiomatous hamartoma. Arch Dermatol. 2006;142:1351–6.
Wang F, Zhao YK, Luo ZY, Gao Q, Wu W, Sarkar R, Luo DQ. Aquagenic cutaneous disorders. J Dtsch Dermatol Ges. 2017;15(6):602–8.
Vale R, Adam DN. Idiopathic aquagenic wrinkling of the palms in sisters. J Dermatol. 2012;39:471–2.
Neri I, Bianchi F, Patrizi A. Transient aquagenic palmar hyperwrinkling: the first instance reported in a young boy. Pediatr Dermatol. 2006;23:39–42.
Tchernev G, Semkova K, Cardoso JC, Ananiev JJ, Wollina U. Aquagenic keratoderma. Two new case reports and a new hypothesis. Indian Dermatol Online J. 2014;5:30–3.
Nishihara E, Hiyama TY, Noda M. Osmosensitivity of transient receptor potential vanilloid 1 is synergistically enhanced by distinct activating stimuli such as temperature and protons. PLoS One. 2011;6:e22246.
Gironi LC, Colombo E, Zottarelli F, et al. Aberrant expression of aquaporin-3 in hereditary papulotranslucent acrokeratoderma and aquagenic palmoplantar keratoderma. Eur J Dermatol. 2018;28:262–3.
Denos C, Dreyfus I, Chiaverini C, et al. Clinical and evolutionary characteristics of a child with aquagenic keratoderma: a retrospective study of 12 patients. Ann Dermatol Venereol. 2018;145:250–6.
Errichetti E, Piccirillo A. Aquagenic keratoderma treated with tap water iontophoresis. Indian J Dermatol. 2015;60:212.
Siah TW, Hampton PJ. The effectiveness of tap water iontophoresis for palmoplantar hyperhidrosis using a Monday, Wednesday, and Friday treatment regime. Dermatol Online J. 2013;19:14.
Bagazgoitia L, Perez-Carmona L, Salguero I, et al. Aquagenic keratoderma: successful treatment with botulinum toxin. Dermatol Surg. 2010;36:434–6.
Garayar Cantero M, Delgado Mucientes C, Muñoz F-LC. Use of botulinum toxin in the treatment of aquagenic keratoderma: one case report. Dermatol Ther. 2018;31:e12689.
Garçon-Michel N, Roguedas-Contios AM, Rault G, Le Bihan J, Ramel S, Revert K, et al. Frequency of aquagenic palmoplantar keratoderma in cystic fibrosis: a new sign of cystic fibrosis? Br J Dermatol. 2010;163:162–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Atzori, L., Ferreli, C., Rongioletti, F. (2021). Aquagenic (Pseudo)keratoderma. In: Rongioletti, F., Smoller, B.R. (eds) New and Emerging Entities in Dermatology and Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-80027-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-80027-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80026-0
Online ISBN: 978-3-030-80027-7
eBook Packages: MedicineMedicine (R0)